AI Model Predicts Which Breast Cancer Patients Can Skip Unnecessary Surgery
Researchers at Heidelberg University Hospital developed a machine learning model combining ultrasound, mammography, MRI and clinical data to predict pathological ...
Tag: pathological complete response
Real-World Data Confirm Immunotherapy Boost for Aggressive Early Breast Cancer
A real-world study of 95 patients in Tokyo confirms that pembrolizumab combined with chemotherapy before and after surgery delivers event-free ...
A Simple Staining Test Predicts Early Return of Colorectal Cancer After Liver Surgery
A pattern-based p53 immunohistochemistry test identified patients with colorectal liver metastases at nearly four times the risk of early cancer ...
Radiotherapy Meets Immunotherapy: New Hope for Hard-to-Treat Rectal Cancer
A new review synthesizes clinical trial evidence showing that combining radiotherapy with immune checkpoint inhibitors can dramatically boost response rates ...
MRI Radiomics Model Predicts Breast Cancer Chemotherapy Response by Reading the Tumor and Its Surroundings
A machine learning study of 351 breast cancer patients shows that MRI radiomics features from both the tumor and its ...
Genomic Scars May Predict Which Rectal Cancers Respond to Radioimmunotherapy
A new study finds that homologous recombination deficiency scores show a surprising non-monotonic relationship with pathological response to short-course radiotherapy ...
Real-World Data Show Total Neoadjuvant Therapy Boosts Tumor Response in Rectal Cancer
A large real-world cohort from Thailand finds that total neoadjuvant therapy doubles pathological complete response rates in locally advanced rectal ...
Mathematical Models Reveal How Shrinking Breast Tumors Move During Therapy
A study of 141 triple-negative breast cancer patients shows that advection terms in mathematical models best capture tumor cell movement ...
Immune Therapy Plus Chemotherapy Erases Stage IIIB Lung Tumor Before Surgery
A stage IIIB lung squamous cell carcinoma patient achieved a pathological complete response after neoadjuvant sugemalimab plus chemotherapy, with biomarker ...
Chemotherapy-Free Drug Combo Shows Promise for Early Triple-Negative Breast Cancer
A phase II trial found that neoadjuvant camrelizumab plus apatinib, a chemotherapy-free combination of immunotherapy and anti-angiogenic therapy, produced manageable ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!